Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

55.30
Delayed Data
As of 4:02pm ET
 -0.33 / -0.59%
Today’s Change
46.17
Today|||52-Week Range
60.34
-4.79%
Year-to-Date
No recent news for Novo Nordisk.

Today’s Trading

Previous close55.63
Today’s open55.36
Day’s range54.69 - 55.44
Volume1,477,182
Average volume (3 months)1,265,165
Market cap$109.1B
Dividend yield1.73%
Data as of 4:02pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.29%
Revenue growth (last year)+1.43%
P/E ratio4.1
Price/Sales9.38
Price/Book20.73

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.17-0.40%
GSKGlaxoSmithKline+0.16+0.36%
ABBVAbbVie+0.51+0.80%
AGNAllergan-1.13-0.45%
Data as of 4:03pm ET, 07/25/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)$0.58
Annual revenue (last year)$16.0B
Annual profit (last year)$5.2B
Net profit margin32.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Rebien Sørensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts

Partner Offers

Search for Jobs